Who
Dirk Huebner
SVP, Cmo
Company insider
Files Form 4 as: SVP, Cmo, Aptevo Therapeutics; Chief Medical Officer, Mersana Therapeutics.
In numbers
- Trades disclosed
- 11
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 30 Nov 2018
- Last trade
- 6 Aug 2026
- Last filed
- 10 Aug 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 6 Aug 2026filed 10 Aug 2026 | APVO Aptevo TherapeuticsBiotechnology | SEC FORM 4 Code M | —638 | filing |
| 6 Aug 2026filed 10 Aug 2026 | APVO Aptevo TherapeuticsBiotechnology | SEC FORM 4 Code F | $635156 at $4.07 | filing |
| 6 Aug 2026filed 10 Aug 2026 | APVO Aptevo Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —638 at $0.00 | filing |
| 6 Aug 2026filed 10 Aug 2026 | APVO Aptevo Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —638 at $0.00 | filing |
| 6 Aug 2026filed 10 Aug 2026 | APVO Aptevo TherapeuticsBiotechnology | SEC FORM 4 Code M | —638 | filing |
| 6 Aug 2026filed 10 Aug 2026 | APVO Aptevo TherapeuticsBiotechnology | SEC FORM 4 Code F | $635156 at $4.07 | filing |
| 6 Aug 2025filed 8 Aug 2025 | APVO Aptevo Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —11,500 at $0.00 | filing |
| 15 Jan 2020filed 16 Jan 2020 | Mersana Therapeuticsoption or derivative | SEC FORM 4 Code A | —82,500 at $0.00 | filing |
| 15 Jan 2020filed 16 Jan 2020 | Mersana Therapeuticsoption or derivative | SEC FORM 4 Code A | —18,333 at $0.00 | filing |
| 17 Jul 2019filed 19 Jul 2019 | Mersana Therapeuticsoption or derivative | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 30 Nov 2018filed 3 Dec 2018 | Mersana Therapeuticsoption or derivative | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.